| 000 | 00896 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250518042656.0 | ||
| 264 | 0 | _c20200420 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1499-2752 | ||
| 024 | 7 |
_a10.3899/jrheum.181392 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMammen, Andrew L | |
| 245 | 0 | 0 |
_aTreatment of Refractory Anti-HMG-CoA Reductase Myopathy: A Role for Rituximab? _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _c06 2019 |
||
| 300 |
_a550-551 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Research Support, N.I.H., Intramural; Comment | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydroxymethylglutaryl CoA Reductases |
| 650 | 0 | 4 | _aMuscular Diseases |
| 650 | 0 | 4 | _aRituximab |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 46 _gno. 6 _gp. 550-551 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3899/jrheum.181392 _zAvailable from publisher's website |
| 999 |
_c29754763 _d29754763 |
||